NYSE:NRZ - New Residential Investment Stock Price Target and Predictions

  • Consensus Rating: Buy
  • Consensus Price Target: $11.50
  • Forecasted Upside: 7.88 %
  • Number of Analysts: 14
  • Breakdown:
  • 0 Sell Ratings
  • 1 Hold Ratings
  • 13 Buy Ratings
  • 0 Strong Buy Ratings
$10.66
▲ +0.13 (1.23%)

This chart shows the closing price for NRZ by one month, three months, or twelve months.

Skip Closing Price Chart
1 month | 3 months | 12 months
Get New New Residential Investment Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for NRZ and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for NRZ

Analyst Price Target is $11.50
▲ +7.88% Upside Potential
This price target is based on 14 analysts offering 12 month price targets for New Residential Investment in the last 3 months. The average price target is $11.50, with a high forecast of $13.00 and a low forecast of $10.00. The average price target represents a 7.88% upside from the last price of $10.66.

This chart shows the closing price for NRZ for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart

Current Consensus is Buy

The current consensus among 14 investment analysts is to buy stock in New Residential Investment. This Buy consensus rating has held steady for over two years.

Past Monthly Recommendations

Move your mouse over past months for details Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart

  • 0 strong buy ratings
  • 7 buy ratings
  • 1 hold ratings
  • 0 sell ratings
1/1/2020
  • 0 strong buy ratings
  • 6 buy ratings
  • 1 hold ratings
  • 0 sell ratings
3/31/2020
  • 0 strong buy ratings
  • 9 buy ratings
  • 1 hold ratings
  • 0 sell ratings
6/29/2020
  • 0 strong buy ratings
  • 9 buy ratings
  • 1 hold ratings
  • 0 sell ratings
9/27/2020
  • 0 strong buy ratings
  • 13 buy ratings
  • 0 hold ratings
  • 0 sell ratings
12/26/2020
  • 0 strong buy ratings
  • 13 buy ratings
  • 0 hold ratings
  • 0 sell ratings
3/26/2021
  • 0 strong buy ratings
  • 13 buy ratings
  • 1 hold ratings
  • 0 sell ratings
5/25/2021
  • 0 strong buy ratings
  • 13 buy ratings
  • 1 hold ratings
  • 0 sell ratings
6/24/2021

Latest Recommendations

  • 0 strong buy ratings
  • 13 buy ratings
  • 1 hold ratings
  • 0 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
5/20/2021Raymond JamesBoost Price TargetOutperform$12.50 ➝ $13.00Low
4/21/2021JonestradingReiterated RatingBuy ➝ HoldN/A
4/20/2021Piper SandlerBoost Price TargetOverweight$11.50 ➝ $13.00Medium
4/16/2021BTIG ResearchBoost Price TargetBuy$12.00 ➝ $13.00Medium
4/15/2021JonestradingDowngradeBuy ➝ HoldMedium
3/25/2021Royal Bank of CanadaInitiated CoverageOutperform$12.00Medium
3/15/2021Credit Suisse GroupBoost Price TargetOutperform$11.00 ➝ $12.00Low
2/16/2021Piper SandlerBoost Price Target$10.00 ➝ $11.00Low
2/10/2021Raymond JamesBoost Price TargetOutperform$11.50 ➝ $12.50Low
1/22/2021JMP SecuritiesBoost Price TargetMarket Outperform$9.50 ➝ $10.00Medium
12/18/2020Keefe, Bruyette & WoodsUpgradeMarket Perform ➝ Outperform$10.50High
12/14/2020Jefferies Financial GroupInitiated CoverageBuy$11.00Low
11/24/2020BTIG ResearchInitiated CoverageBuyLow
11/24/2020B. RileyBoost Price TargetBuy$9.50 ➝ $11.50Medium
11/23/2020Raymond JamesBoost Price TargetOutperform$10.50 ➝ $11.50Low
11/6/2020Wolfe ResearchInitiated CoverageOutperformMedium
10/20/2020Compass PointInitiated CoverageBuy$11.00High
10/19/2020Credit Suisse GroupBoost Price TargetOutperform$10.00 ➝ $11.00Medium
9/24/2020UBS GroupInitiated CoverageBuy$11.00Medium
9/17/2020Credit Suisse GroupReiterated RatingBuyLow
9/8/2020Credit Suisse GroupReiterated RatingBuyLow
8/20/2020Raymond JamesBoost Price TargetOutperform$8.50 ➝ $10.50Medium
7/27/2020ArgusUpgradeHold ➝ Buy$10.00Low
7/16/2020Piper SandlerUpgradeNeutral ➝ Overweight$8.50 ➝ $9.50Medium
6/23/2020B. RileyReiterated RatingBuy$9.00High
6/12/2020JMP SecuritiesLower Price TargetOutperform$17.00 ➝ $9.50Low
5/28/2020Credit Suisse GroupReiterated RatingBuy$10.00High
5/27/2020Piper SandlerBoost Price TargetNeutral$7.00 ➝ $8.50Low
4/2/2020BTIG ResearchLower Price Target$18.00 ➝ $10.50High
4/2/2020ArgusDowngradeBuy ➝ HoldHigh
2/13/2020Nomura SecuritiesBoost Price TargetBuy$18.50 ➝ $20.00Low
1/13/2020B. RileyReiterated RatingBuyLow
12/31/2019ArgusInitiated CoverageBuy$18.00Low
12/2/2019Compass PointInitiated CoverageBuy$19.00Low
11/14/2019Piper Jaffray CompaniesDowngradeOverweight ➝ Neutral$16.00High
10/25/2019B. RileySet Price TargetBuy$18.50N/A
10/4/2019Piper Jaffray CompaniesLower Price TargetOverweight$18.00 ➝ $16.00Low
9/6/2019BTIG ResearchInitiated CoverageBuy$18.00 ➝ $18.00Medium
8/29/2019B. RileySet Price TargetBuy$19.00Low
8/21/2019B. RileySet Price TargetBuy$19.00High
8/19/2019WedbushReiterated RatingOutperformLow
3/27/2019Nomura SecuritiesInitiated CoverageBuy$18.50Low
1/4/2019Credit Suisse GroupReiterated RatingBuy$18.00Low
10/5/2018Raymond JamesInitiated CoverageOutperform ➝ Outperform$20.00Low
7/25/2018BarclaysBoost Price TargetOverweight ➝ Overweight$19.00 ➝ $21.00Low
2/13/2018B. RileySet Price TargetBuy$19.00Low
1/18/2018WedbushUpgradeNeutral ➝ Outperform$20.00Medium
11/29/2017B. RileyReiterated RatingBuy$19.25Low
11/1/2017B. RileyReiterated RatingBuyN/A
10/30/2017(FBRC)Reiterated RatingBuy$19.25N/A
10/24/2017BarclaysBoost Price TargetPositive ➝ Overweight$16.00 ➝ $19.00N/A
10/9/2017(FBRC)Reiterated RatingBuy$17.50N/A
9/14/2017Keefe, Bruyette & WoodsReiterated RatingBuy$18.00Low
8/27/2017Piper Jaffray CompaniesReiterated RatingBuy$18.00Low
8/3/2017Keefe, Bruyette & WoodsReiterated RatingBuy$18.00Low
7/10/2017(FBRC)Reiterated RatingBuy$17.50Low
6/20/2017WedbushDowngradeOutperform ➝ Neutral$17.00 ➝ $16.50High
6/6/2017Keefe, Bruyette & WoodsSet Price TargetBuy$17.00Low
5/2/2017(FBRC)Reiterated RatingOutperform$17.50Low
4/23/2017(FBRC)Reiterated RatingOutperform$17.50Low
3/28/2017(FBRC)Reiterated RatingOutperform$17.50Low
2/22/2017(FBRC)Boost Price TargetOutperform ➝ Outperform$16.75 ➝ $17.50N/A
2/6/2017Keefe, Bruyette & WoodsReiterated RatingOutperformN/A
1/31/2017Compass PointUpgradeNeutral ➝ BuyN/A
11/19/2016BarclaysSet Price TargetBuy$16.00N/A
11/3/2016(FBRC)Reiterated RatingBuyN/A
11/3/2016Nomura SecuritiesReiterated RatingHold$15.00N/A
10/26/2016Nomura SecuritiesInitiated CoverageNeutralN/A
10/5/2016WedbushInitiated CoverageOutperform$17.00N/A
9/11/2016Credit Suisse GroupReiterated RatingBuy$17.00N/A
9/9/2016Piper Jaffray CompaniesReiterated RatingOverweight$16.00N/A
8/10/2016BarclaysBoost Price TargetOverweight$15.00 ➝ $16.00N/A
8/8/2016Credit Suisse GroupSet Price TargetBuy$17.00N/A
(Data available from 6/24/2016 forward)
New Residential Investment logo
New Residential Investment Corp., a real estate investment trust, focuses on investing in and managing residential mortgage related assets in the United States. It operates through five segments: Origination, Servicing, MSR Related Investments, Residential Securities and Loans, and Consumer Loans. The company invests in excess mortgage servicing rights (MSRs) on residential mortgage loans; and in servicer advances, including the basic fee component of the related MSRs. It also invests in real estate securities and residential mortgage loans, as well as in consumer loans, including unsecured and homeowner loans. The company qualifies as a real estate investment trust for federal income tax purposes. It generally would not be subject to federal corporate income taxes if it distributes at least 90% of its taxable income to its stockholders. New Residential Investment Corp. was founded in 2011 and is based in New York, New York.
Read More

Today's Range

Now: $10.66
Low: $10.54
High: $10.66

50 Day Range

MA: $10.56
Low: $9.89
High: $11.21

52 Week Range

Now: $10.66
Low: $6.38
High: $11.48

Volume

99,359 shs

Average Volume

5,692,002 shs

Market Capitalization

$4.97 billion

P/E Ratio

10.88

Dividend Yield

7.51%

Beta

1.91

Frequently Asked Questions

What sell-side analysts currently cover shares of New Residential Investment?

The following Wall Street analysts have issued stock ratings on New Residential Investment in the last year: Argus, B. Riley, BTIG Research, Compass Point, Credit Suisse Group AG, Jefferies Financial Group Inc., JMP Securities, Jonestrading, Keefe, Bruyette & Woods, Piper Sandler, Raymond James, Royal Bank of Canada, UBS Group AG, Wolfe Research, and Zacks Investment Research.
View the latest analyst ratings for NRZ.

What is the current price target for New Residential Investment?

12 Wall Street analysts have set twelve-month price targets for New Residential Investment in the last year. Their average twelve-month price target is $11.50, suggesting a possible upside of 8.6%. Raymond James has the highest price target set, predicting NRZ will reach $13.00 in the next twelve months. JMP Securities has the lowest price target set, forecasting a price of $10.00 for New Residential Investment in the next year.
View the latest price targets for NRZ.

What is the current consensus analyst rating for New Residential Investment?

New Residential Investment currently has 1 hold rating and 13 buy ratings from Wall Street analysts. The stock has a consensus analyst rating of "Buy." A "buy" rating indicates that analysts believe NRZ will outperform the market and that investors should add to their positions of New Residential Investment.
View the latest ratings for NRZ.

What other companies compete with New Residential Investment?

How do I contact New Residential Investment's investor relations team?

New Residential Investment's physical mailing address is 1345 AVENUE OF THE AMERICAS, NEW YORK NY, 10105. The real estate investment trust's listed phone number is 212-798-3150 and its investor relations email address is [email protected] The official website for New Residential Investment is www.newresi.com.